Terror, Joy, Triumph: Learning Resilience as a Pediatric Neurosurgeon Jay Wellons, MD, reflects on his journey and challenges as a pediatric neurosurgeon Sep 13, 2022 podcast
Tecovirimat Safe in Monkeypox, but Efficacy Is Less Clear Data support use in patients with or at risk for severe disease, CDC researchers say Sep 12, 2022
Survival Bump in Unfit NSCLC With First-Line Immunotherapy Atezolizumab doubles OS at 2 years versus chemotherapy in those ineligible for platinum doublets Sep 12, 2022
Are Doctors Getting Their COVID Boosters? Ƶ asked a dozen doctors about their plans for the latest bivalent shots Sep 12, 2022
Neoadjuvant Cemiplimab Active in Resectable Cutaneous Squamous Cell Carcinoma Pathologic complete responses seen in 63% of patients in phase II data Sep 12, 2022
Three Adjuvant Immunotherapy Trials Flop in Renal Cell Carcinoma Studies appear to contradict benefit previously shown with pembrolizumab in this setting Sep 12, 2022
Fish Oil Supplement Fails to Reduce Hip Fractures Further bad news for omega-3 fatty acids in VITAL trial analysis Sep 12, 2022
What's Left for Nivolumab to Prove in Stage IIIA NSCLC? Nicholas Rohs, MD, discusses the results from the NADIM II trial Sep 12, 2022 video
Colorectal Cancer Burden on the Rise in Developed Countries Global study predicts an uptick in incidence and mortality through 2040 Sep 12, 2022
Vitamin D Levels, Supplements Not Linked to COVID Infection Risk High or low levels made no difference among healthy people Sep 12, 2022
Combination Therapy Shows Promise for NSCLC That Progresses on Osimertinib About half of patients responded to tepotinib plus osimertinib, but efficacy ceiling persists Sep 12, 2022
Cardiovascular Risks Not Increased With Denosumab Large observational databases mitigate concerns about the osteoporosis therapy Sep 12, 2022
'Striking' Colon Cancer Data Spur Mid-Presentation Ovation at ESMO Preoperative immunotherapy combo in dMMR disease yields major pathologic response in 95% Sep 12, 2022
Tumor Infiltrating Lymphocytes Reemerge as Potential Melanoma Option More than 50% increase in 6-month PFS versus ipilimumab after progression on first-line anti-PD-1 Sep 12, 2022
First TYK2 Inhibitor for Psoriasis Wins FDA Approval Deucravacitinib significantly outperformed apremilast in two randomized trials Sep 11, 2022
Some Reassurance That a Cuffless BP Sensor Works Regardless of Body Fat, Skin Color Study of the Biobeats sensor prompted by concerns from the FDA Sep 11, 2022
Add-On Pembrolizumab Misses in Locally Advanced Head and Neck Cancer Post hoc data point to possible benefit in patients with higher PD-L1 levels Sep 11, 2022
Does the Picture of HTN Disorders in Children Vary by Age, Preterm Birth? Preliminary findings from an epidemiological study of pediatric hypertension Sep 11, 2022
Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era? Algorithm held its own, but not many study patients were on biologics Sep 11, 2022
Do Some Ƶ Need to Get Better at Documenting Hypertension in Patient Notes? Study finds settings where BP documentation is especially lax Sep 11, 2022
Locking Down a Link Between Pollution and EGFR-Mutated Lung NSCLC Study also shed lights on what may lead to lung cancer in never smokers Sep 11, 2022
BP Lowering in Pregnant Women Continues to Take Shape Clinical guidance released, further studies planned in CHAP trial aftermath Sep 10, 2022
'Potential New Standard' for Progressing Desmoid Tumors Risk of disease progression or death reduced by 71% with oral gamma secretase inhibitor Sep 10, 2022
Targeted Combo Flops as First-Line Treatment in Advanced Breast Cancer No clinical benefit boost with anti-CD73 oleclumab added to durvalumab and chemo Sep 10, 2022
Good News, Bad News for Global Hip Fracture Rates Incidence has declined, but burden will increase as older population grows Sep 10, 2022
CDC: More Kids Hospitalized With Respiratory Disease Linked to Non-Polio Enterovirus Infection associated with rare neurologic complication that causes limb weakness, agency says Sep 10, 2022
Whole-Person Care Can Make Us Better Healers Illness is sometimes more than what's on the surface Sep 10, 2022
Maintenance PARP Inhibition Boosts OS in Two Ovarian Cancer Trials Results from SOLO-1 and PAOLA-1 show "clinically meaningful" long-term results with olaparib Sep 09, 2022
Health System Warns Exemptions to COVID Vaccines May Expire With New Options Holdouts who used religious exemptions to avoid vaccination can get Novavax now Sep 09, 2022
Pharmacist-Led Hypertension Clinics Able to Lower BP Within Weeks Broader implementation of programs hinges on state policies Sep 09, 2022
Worse OS With Rucaparib First in Trial of Recurrent, BRCA+ Ovarian Cancer A closer look at why PARP inhibitor's third-line indication was withdrawn Sep 09, 2022
Antibody-Drug Conjugate Prolongs Survival in Metastatic Breast Cancer Positive outcome with sacituzumab govitecan leads to questions about ADC sequencing Sep 09, 2022
Physician Sentenced to Prison for Illegally Prescribing Anti-Anxiety Drug The osteopathic doctor pleaded guilty to prescribing Xanax to people who were not his patients Sep 09, 2022
Simone Gold of America's Frontline Doctors Released From Prison Early Disinformation physician complained of 8 days of solitary confinement for refusing COVID vaccine Sep 09, 2022
Glutamine for Burn Patients: Time for a Rethink Randomized RE-ENERGIZE trial shows no impact on major outcomes Sep 09, 2022
Our Perception of Obesity Needs an Overhaul Changing how we think about the disease allows us to more effectively talk to and treat patients Sep 09, 2022
Robotic Surgery Tops Laparoscopic Surgery for Middle and Low Rectal Cancer Randomized trial shows fewer positive circumferential resection margins with robotic technique Sep 09, 2022
Taking Two Common Supplements in Pregnancy Reduced Risk of Croup in Kids Fish oil and high-dose vitamin D led to 38% and 40% reduced risks of croup in kids under age 3 Sep 09, 2022
Clinical Challenges: The Low-Down on HER2-Low The new category could encompass a majority of metastatic, unresectable breast cancers Sep 09, 2022
